ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AG9. A total of 7 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2015. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $28,045,000 | -18.8% | 11,246,000 | +21.6% | 0.82% | -13.1% |
| Q4 2015 | $34,551,000 | +45.1% | 9,246,000 | -5.0% | 0.94% | -11.5% |
| Q3 2015 | $23,809,000 | -5.2% | 9,728,000 | +34.6% | 1.06% | -2.0% |
| Q2 2015 | $25,104,000 | -46.6% | 7,228,000 | -40.9% | 1.09% | -40.2% |
| Q1 2015 | $46,971,000 | -30.9% | 12,228,000 | -32.9% | 1.82% | -33.2% |
| Q4 2014 | $67,928,000 | +54.2% | 18,228,000 | 0.0% | 2.72% | +59.0% |
| Q3 2014 | $44,066,000 | +1.5% | 18,228,000 | -7.6% | 1.71% | -0.2% |
| Q2 2014 | $43,426,000 | +15.8% | 19,728,000 | +41.1% | 1.71% | +7.1% |
| Q1 2014 | $37,505,000 | -11.8% | 13,978,000 | -18.2% | 1.60% | -14.3% |
| Q4 2013 | $42,505,000 | +416.3% | 17,096,000 | +388.5% | 1.87% | +330.0% |
| Q3 2013 | $8,232,000 | – | 3,500,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | 35,441,000 | $87,701,000 | 2.49% |
| EQUITEC SPECIALISTS, LLC | 3,112,000 | $7,761,000 | 1.89% |
| WHITEBOX ADVISORS LLC | 11,246,000 | $28,045,000 | 0.82% |
| FMR LLC | 6,000,000 | $14,963,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 300,000 | $730,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5,000 | $12,000 | 0.00% |